NasdaqGS - Nasdaq Real Time Price USD

IDEXX Laboratories, Inc. (IDXX)

Compare
418.05
-14.31
(-3.31%)
At close: January 10 at 4:00:02 PM EST
417.01
-1.04
(-0.25%)
After hours: January 10 at 7:29:46 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,844,817.00
3,660,953.00
3,367,324.00
3,215,360.00
2,706,655.00
Cost of Revenue
1,510,383.00
1,470,983.00
1,362,986.00
1,325,928.00
1,135,615.00
Gross Profit
2,334,434.00
2,189,970.00
2,004,338.00
1,889,432.00
1,571,040.00
Operating Expense
1,222,481.00
1,092,842.00
1,105,573.00
957,404.00
876,516.00
Operating Income
1,111,953.00
1,097,128.00
898,765.00
932,028.00
694,524.00
Net Non Operating Interest Income Expense
-18,841.00
-35,952.00
-38,793.00
-29,374.00
-32,539.00
Pretax Income
1,093,112.00
1,061,176.00
859,972.00
902,654.00
661,985.00
Tax Provision
226,873.00
216,134.00
180,883.00
157,810.00
79,854.00
Net Income Common Stockholders
866,239.00
845,042.00
679,089.00
744,845.00
581,776.00
Diluted NI Available to Com Stockholders
866,239.00
845,042.00
679,089.00
744,845.00
581,776.00
Basic EPS
10.46
10.17
8.12
8.74
6.82
Diluted EPS
10.36
10.06
8.03
8.60
6.71
Basic Average Shares
82,778.75
83,066.00
83,623.00
85,200.00
85,342.00
Diluted Average Shares
83,594.00
83,978.00
84,600.00
86,572.00
86,722.00
Total Operating Income as Reported
1,111,953.00
1,097,128.00
898,765.00
932,028.00
694,524.00
Total Expenses
2,732,864.00
2,563,825.00
2,468,559.00
2,283,332.00
2,012,131.00
Net Income from Continuing & Discontinued Operation
866,239.00
845,042.00
679,089.00
744,845.00
581,776.00
Normalized Income
866,239.00
845,042.00
679,089.00
744,845.00
581,776.00
Interest Income
14,131.00
5,629.00
1,065.00
434.00
586.00
Interest Expense
32,972.00
41,581.00
39,858.00
29,808.00
33,125.00
Net Interest Income
-18,841.00
-35,952.00
-38,793.00
-29,374.00
-32,539.00
EBIT
1,126,084.00
1,102,757.00
899,830.00
932,462.00
695,110.00
EBITDA
1,252,051.00
1,217,665.00
1,011,730.00
1,037,058.00
791,108.00
Reconciled Cost of Revenue
1,510,383.00
1,470,983.00
1,362,986.00
1,325,928.00
1,135,615.00
Reconciled Depreciation
125,967.00
114,908.00
111,900.00
104,596.00
95,998.00
Net Income from Continuing Operation Net Minority Interest
866,239.00
845,042.00
679,089.00
744,845.00
581,776.00
Normalized EBITDA
1,252,051.00
1,217,665.00
1,011,730.00
1,037,058.00
791,108.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 6/21/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MEDP Medpace Holdings, Inc.
350.87
-1.05%
 
WAT Waters Corporation
380.35
+1.64%
 
MTD Mettler-Toledo International Inc.
1,210.99
-2.85%
 
DHR Danaher Corporation
235.07
-1.27%
 
TMO Thermo Fisher Scientific Inc.
542.31
-0.48%
 
LH Labcorp Holdings Inc.
232.00
-0.99%
 
IQV IQVIA Holdings Inc.
203.27
-0.51%
 
ICLR ICON Public Limited Company
218.22
-0.51%
 
DGX Quest Diagnostics Incorporated
151.79
-1.45%
 
A Agilent Technologies, Inc.
137.47
+0.34%